US 8603808
Leishmania vaccine using sand fly salivary immunogen
granted A61KA61K2039/53A61K2039/58
Quick answer
US patent 8603808 (Leishmania vaccine using sand fly salivary immunogen) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon Dec 05 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America as Represented by the Secretary of the Department of Health and Human Services
- Grant date
- Tue Dec 10 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 05 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K2039/53, A61K2039/58, A61K39/00, A61K39/0003